-
Jerri Edwards, a professor of psychiatry and behavioral neurosciences at the USF Health Morsani College of Medicine, talks about the study.
-
It can be hard for people with dementia and caregivers to enjoy life’s simple pleasures, like eating out. Some businesses are already making a difference, offering a controlled environment and specially trained staff.
-
A settlement has been reached for the families of victims and survivors of the Champlain Towers South collapse in Surfside. Plus, new research predicts Florida will have one of the fastest growing rates of Alzheimer’s by the middle of this decade.
-
Medicare has proposed limiting coverage of Aduhelm and several prominent groups representing patients and families are pressing to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.
-
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
-
New monitoring technology is helping family caregivers manage the relentless task of looking out for older adults with cognitive decline. But it's not an option for everyone.
-
The condition can be an early signal of Alzheimer’s but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
-
The FDA approves new prescribing instructions for Aduhelm to address confusion over who should get the drug, saying it is appropriate for patients with early or mild Alzheimer’s.
-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.
-
Researchers are looking to enroll 7,600 people in the cognitive training study, including 3,000 in the greater Tampa Bay region.
-
Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.
-